Athanase Innovation Past Earnings Performance
Past criteria checks 0/6
Athanase Innovation's earnings have been declining at an average annual rate of -34.9%, while the Capital Markets industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 16.7% per year.
Key information
-34.9%
Earnings growth rate
-25.3%
EPS growth rate
| Capital Markets Industry Growth | 16.3% |
| Revenue growth rate | 16.7% |
| Return on equity | -8.9% |
| Net Margin | -138.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Athanase Innovation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 41 | -56 | 87 | 0 |
| 30 Sep 23 | 36 | -44 | 88 | 0 |
| 30 Jun 23 | 12 | -67 | 86 | 0 |
| 31 Mar 23 | -25 | -107 | 81 | 0 |
| 31 Dec 22 | -45 | -115 | 71 | 0 |
| 30 Sep 22 | -55 | -115 | 56 | 0 |
| 30 Jun 22 | -34 | -104 | 44 | 0 |
| 31 Mar 22 | 13 | -61 | 35 | 0 |
| 31 Dec 21 | 22 | -27 | 23 | 0 |
| 30 Sep 21 | 18 | -34 | 14 | 0 |
| 31 Dec 20 | 0 | -9 | 0 | 0 |
Quality Earnings: ATIN is currently unprofitable.
Growing Profit Margin: ATIN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ATIN is unprofitable, and losses have increased over the past 5 years at a rate of 34.9% per year.
Accelerating Growth: Unable to compare ATIN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ATIN is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (32.1%).
Return on Equity
High ROE: ATIN has a negative Return on Equity (-8.87%), as it is currently unprofitable.